13 results
-
MSAC Consultation Survey - Application 1822
MSAC application 1822 F-18 Fluorodeoxyglucose (FDG) positron emission tomography (PET) for evaluation of complex infection. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian... MoreCloses 6 November 2026 -
MSAC Consultation Survey - Application 1831
MSAC Application 1831 Kappa free-light chain (kFLC) index testing for the diagnosis of multiple sclerosis (MS). Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... MoreCloses 6 November 2026 -
MSAC Consultation Survey - Application 1832
MSAC Application 1832 Detection of measurable residual disease (MRD) in patients with multiple myeloma (MM). Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... MoreCloses 6 November 2026 -
MSAC Consultation Survey - Application 1830
MSAC application 1830 Genetic testing to identify homologous recombination repair (HRR) gene alterations in patients with metastatic castration-sensitive prostate cancer (mCSPC) to determine eligibility for treatment with PBS subsidised talazoparib. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation... MoreCloses 6 November 2026 -
MSAC Consultation Survey - Application 1829
MSAC application 1829 Anti-Müllerian hormone testing for identification of Polycystic Ovarian Morphology, to support the diagnosis of Polyendrocrine Metabolic Ovarian Syndrome (PMOS). Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a... MoreCloses 6 November 2026 -
MSAC Consultation Survey - Application 1828
MSAC application 1828 Review of devices used in catheter-based cardiac ablation for the treatment of patients with cardiac arrhythmias. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the... MoreCloses 6 November 2026 -
MSAC Consultation Survey - Application 1629.1
MSAC Application 1629.1 Defensive Antibacterial Coating (DAC) with antibiotics for reducing the risk of periprosthetic surgical site infection. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology... MoreCloses 6 November 2026 -
MSAC Consultation Survey - Application 1835
MSAC Application 1835 Lifileucel for the treatment of patients with previously treated unresectable or metastatic melanoma. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian... MoreCloses 6 November 2026 -
MSAC Consultation Survey - Application 1834
MSAC Application 1834 Efanesoctocog alfa for routine prophylaxis in patients with haemophilia A. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It... MoreCloses 6 November 2026 -
MSAC Consultation Survey - Application 1802
MSAC application 1802 - Supervised oral food challenge (OFC) in patients with suspected food allergy. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... MoreCloses 12 February 2027 -
CEEU/HTA Updates
Receive regular HTA Engage e-newsletters for updates on HTA activities and announcements from the CEEU, including open consultation dates for PBAC and MSAC meeting agenda items. MoreCloses 1 June 2028 -
MSAC Updates
Subscribe to MSAC email bulletins on the MSAC meeting agendas and consultations, and important updates. MoreCloses 1 June 2028 -
PBAC Updates
Subscribe to PBS.gov.au email notification of the Pharmaceutical Benefits Scheme (PBS) news, including PBAC meeting agendas, consultations and outcomes. MoreCloses 1 June 2028
13 results.
Page 1 of 1